Form D · Biotechnology
AMPHP, INC.
Park City, UT · CIK 0001856578
Offering snapshot reported Nov 16, 2023 · SEC filing
- Reported sold
- $32.1M Offering amount: $32.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 1, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2023 | Initial | $32,114,924 | No comparison | 2 | SEC filing |
| May 20, 2022 | Initial | $5,675,617 | No comparison | 28 | SEC filing |
| Apr 14, 2021 | Initial | $1,353,485 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-497488
Source: Form D, filed Nov 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Byers | Director, Executive |
| Naomi Clarkson | Executive |
| Kevin Datoo | Director |
| Erica Good | Director, Executive |
| Doug Janzen | Director |
| Jared La Mantia | Executive |
| Peter Rahal | Director |
| Melanie Strong | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1090 Center Drive
Park City, UT, 84098
Park City, UT, 84098